We are live on ! Find out more
CAM

ClariVest Asset Management Portfolio holdings

AUM $980M
1-Year Est. Return 60.89%
This Fund
S&P 500
This Quarter Est. Return
+15.89%
1 Year Est. Return
+60.89%
3 Year Est. Return
+106.43%
5 Year Est. Return
+337.88%
10 Year Est. Return
+1,091.18%
AUM
$1.99B
AUM Growth
-$247M
Cap. Flow
-$474M
Cap. Flow %
-23.78%
Top 10 Hldgs %
40.01%
Holding
790
New
68
Increased
174
Reduced
262
Closed
133

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$34.3M
2
MSFT icon
Microsoft
MSFT
+$32.7M
3
URI icon
United Rentals
URI
+$22.4M
4
QCOM icon
Qualcomm
QCOM
+$22.3M
5
OLN icon
Olin
OLN
+$16.8M

Sector Composition

Rank Sector Weight
1 Technology 46.02%
2 Healthcare 15.22%
3 Consumer Discretionary 11.08%
4 Communication Services 8.91%
5 Industrials 7.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HCP
351
DELISTED
HashiCorp, Inc. Class A Common Stock
HCP
$475K 0.02%
18,140
-1,300
-7% -$38.1K
HROW icon
352
Harrow
HROW
$1.51B
$472K 0.02%
24,794
+8,194
+49% +$180K
HSII
353
DELISTED
Heidrick & Struggles
HSII
$472K 0.02%
17,814
+3,305
+23% +$87.2K
KRTX
354
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$472K 0.02%
2,174
-1,075
-33% -$230K
ITOS
355
DELISTED
iTeos Therapeutics
ITOS
$467K 0.02%
35,255
+16,623
+89% +$237K
VNDA icon
356
Vanda Pharmaceuticals
VNDA
$302M
$442K 0.02%
66,968
+24,481
+58% +$157K
ARRY icon
357
Array Technologies
ARRY
$855M
$437K 0.02%
19,322
-1,400
-7% -$30K
MQ icon
358
Marqeta
MQ
$1.66B
$434K 0.02%
22,251
-1,675
-7% -$30.4K
ICPT
359
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$429K 0.02%
+38,728
New +$540K
GEO icon
360
The GEO Group
GEO
$4.04B
$406K 0.02%
56,718
+10,314
+22% +$79.9K
IMVT icon
361
Immunovant
IMVT
$8.25B
$406K 0.02%
21,377
-1,600
-7% -$29.8K
SHLS icon
362
Shoals Technologies Group
SHLS
$1.5B
$317K 0.02%
12,423
-900
-7% -$20.8K
NTLA icon
363
Intellia Therapeutics
NTLA
$1.67B
$301K 0.02%
7,381
-500
-6% -$20.3K
EEMS icon
364
iShares MSCI Emerging Markets Small-Cap ETF
EEMS
$373M
$216K 0.01%
4,040
EWT icon
365
iShares MSCI Taiwan ETF
EWT
$10.7B
$91K ﹤0.01%
1,933
SMIN icon
366
iShares MSCI India Small-Cap ETF
SMIN
$776M
$78K ﹤0.01%
1,346
EWY icon
367
iShares MSCI South Korea ETF
EWY
$24.1B
$73K ﹤0.01%
1,153
KSA icon
368
iShares MSCI Saudi Arabia ETF
KSA
$621M
$24K ﹤0.01%
566
RGA icon
369
Reinsurance Group of America
RGA
$16.1B
$20K ﹤0.01%
142
-3
-2% -$427
ORCL icon
370
Oracle
ORCL
$423B
$19K ﹤0.01%
156
+121
+346% +$12.5K
ZBH icon
371
Zimmer Biomet
ZBH
$18.4B
$18K ﹤0.01%
118
+62
+111% +$8.43K
ELV icon
372
Elevance Health
ELV
$85.5B
$15K ﹤0.01%
34
-2
-6% -$923
CNYA icon
373
iShares MSCI China A ETF
CNYA
$208M
$14K ﹤0.01%
493
GILD icon
374
Gilead Sciences
GILD
$165B
$14K ﹤0.01%
185
AMAT icon
375
Applied Materials
AMAT
$428B
$12K ﹤0.01%
80
-11
-12% -$1.38K

Similar funds

ClariVest Asset Management's Q2 2023 Portfolio in Review

As of Q2 2023, ClariVest Asset Management held 790 positions worth $1.99B, down 11% from $2.24B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

ClariVest Asset Management withdrew a net $474M in Q2 2023, closing 133 positions and reducing 262 holdings. Its most notable exit was Qualcomm, an estimated $22.3M position sold in full.

By sector, the portfolio is most concentrated in Technology at 46% of assets, up from 42% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, ClariVest Asset Management opened a new position in Adobe worth $27.2M.

  • ClariVest Asset Management's largest Q2 2023 buy was Adobe: 55,575 shares worth $27.2M.
  • ClariVest Asset Management added most to Eli Lilly in Q2 2023, an estimated $14.2M increase.
  • ClariVest Asset Management's biggest Q2 2023 reduction was Apple, cutting an estimated $34.3M.
  • ClariVest Asset Management fully exited Qualcomm in Q2 2023, selling an estimated $22.3M.
  • ClariVest Asset Management's ten largest holdings make up 40% of its $1.99B portfolio in Q2 2023.
  • ClariVest Asset Management opened 68 new positions and closed 133 in Q2 2023.
  • ClariVest Asset Management's portfolio value fell 11% quarter-over-quarter to $1.99B.

Based on ClariVest Asset Management's 13F filing for Q2 2023, filed 14 Aug 2023.